Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
about
Gene Therapy Applications to Cancer TreatmentAre the currently existing anti-human papillomavirus vaccines appropriate for the developing world?More men than women make mucosal IgA antibodies to Human papillomavirus type 16 (HPV-16) and HPV-18: a study of oral HPV and oral HPV antibodies in a normal healthy population.Human papillomavirus-specific antibody status in oral fluids modestly reflects serum status in human immunodeficiency virus-positive individuals.Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysisThe relationship between anti-HPV-16 IgG seropositivity and cancer of the cervix, anogenital organs, oral cavity and pharynx, oesophagus and prostate in a black South African population.Age-specific human papillomavirus antibody and deoxyribonucleic acid prevalence: a global reviewReactivity to human papillomavirus type 16 L1 virus-like particles in sera from patients with genital cancer and patients with carcinomas at five different extragenital sitesCross-sectional study on the prevalence of HPV antibodies in the general population of the Czech Republic.Chimerically fused antigen rich of overlapped epitopes from latent membrane protein 2 (LMP2) of Epstein-Barr virus as a potential vaccine and diagnostic agentAntibody response to human papillomavirus vaccination and natural exposure in individuals with Fanconi Anemia.Detection of antibodies against epidermodysplasia verruciformis-associated canine papillomavirus 3 in sera of dogs from Europe and Africa by enzyme-linked immunosorbent assay.Serologic response to human oncogenic papillomavirus types 16, 18, 31, 33, 39, 58 and 59 virus-like particles in colombian women with invasive cervical cancer.
P2860
Q24792808-9CA4D937-3FF9-4859-B903-9F9F8D2E1133Q27692056-C7F643EB-4D2B-4AC0-B9F8-093B9A684E29Q33246180-DE22C90E-18D6-46CE-9647-092D95829104Q34995733-46318BC0-A564-4686-8963-95C687508128Q35413976-1261E4B0-E5D8-4C36-A0C7-20D1416AE4F3Q35677525-49A5022C-DAE6-4A17-A1F3-850E9AF886B7Q36609068-A4738999-A8BE-41A9-A1B3-D8EB1C04F127Q36646726-187F3F0E-1672-4702-8B13-088B189D19CAQ36677322-A8A48BFD-F592-41F5-AD3D-D62CB5C0F8C4Q37101134-16E8CE3B-B3CF-4DDA-BEFD-81C41A620D17Q43168107-EA78D211-1F46-467A-9879-EF37F6696111Q43204000-16A130D9-81DC-40D8-A0BB-FABC25B9A746Q45733679-6D3ABCDE-A912-4D74-85BB-5681F9D1F87E
P2860
Seroresponses to human papillomavirus types 16, 18, 31, 33, and 45 virus-like particles in South African women with cervical cancer and cervical intraepithelial neoplasia.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Seroresponses to human papillo ...... cal intraepithelial neoplasia.
@en
Seroresponses to human papillo ...... cal intraepithelial neoplasia.
@nl
type
label
Seroresponses to human papillo ...... cal intraepithelial neoplasia.
@en
Seroresponses to human papillo ...... cal intraepithelial neoplasia.
@nl
prefLabel
Seroresponses to human papillo ...... cal intraepithelial neoplasia.
@en
Seroresponses to human papillo ...... cal intraepithelial neoplasia.
@nl
P2093
P2860
P1476
Seroresponses to human papillo ...... cal intraepithelial neoplasia.
@en
P2093
A L Williamson
C M Dehaeck
D J Marais
P2860
P304
P356
10.1002/(SICI)1096-9071(200004)60:4<403::AID-JMV7>3.0.CO;2-6
P577
2000-04-01T00:00:00Z